Mitral Valve Screening Survey for Mitral Valve Disease
This study is a survey for people with mitral valve disease who were considered for a transcatheter mitral valve intervention (TMVI) but did not pass the screening. It aims to understand the characteristics and health journey of these patients. Researchers will collect information on your demographics, imaging results, and health outcomes. The main goal is to see how long people live after one year. This study is currently unclear about its recruitment status and plans to include 1000 participants. You can join if you are 18 or older and failed screening for TMVI. You cannot join if you are under 18, unwilling to give consent, or if you proceeded with TMVI.
- Study design
- This is an observational study that aims to enroll 1000 participants. It is a multicenter registry, meaning data will be collected from several different locations.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants' all-cause mortality will be measured at 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Mitral Valve Screening Survey
At a glance
Conditions
Where it's being run
16 sites across 15 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- All-cause mortality1 year